Plant ID: NPO18435
Plant Latin Name: Tylophora atrofolliculata
Taxonomy Genus: Tylophora
Taxonomy Family: Apocynaceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
n.a.
China
PTPN1; | |
PTGES; ALOX12; HSD11B1; | |
JUN; | |
MAPT; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | PTGES | Prostaglandin E synthase | O14684 | CHEMBL5658 |
Enzyme_unclassified | ALOX12 | Arachidonate 12-lipoxygenase | P18054 | CHEMBL3687 |
Enzyme_unclassified | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | P28845 | CHEMBL4235 |
Protein Phosphatase | PTPN1 | Protein-tyrosine phosphatase 1B | P18031 | CHEMBL335 |
Transcription Factor | JUN | Proto-oncogene c-JUN | P05412 | CHEMBL4977 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0019369; arachidonic acid metabolic process | 1.145E-06 | 8.312E-03 | ALOX12, CYP2C9, PTGES |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 9.002E-07 | 8.312E-03 | CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 2.250E-06 | 1.225E-02 | CYP2C9, CYP3A4 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 9.886E-06 | 2.153E-02 | CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 9.886E-06 | 2.153E-02 | CYP2C9, CYP3A4 |
BP | GO:0002376; immune system process | GO:0001774; microglial cell activation | 2.035E-05 | 4.028E-02 | JUN, MAPT |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 3.030E-05 | 5.075E-02 | ALOX12, CYP2C9, CYP3A4 |
MF | GO:0005488; binding | GO:0051721; protein phosphatase 2A binding | 5.643E-05 | 7.228E-02 | MAPT, PTPN1 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 8.365E-05 | 8.674E-02 | CYP2C9, CYP3A4 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 1.473E-04 | 1.283E-01 | CYP2C9, CYP3A4 |
CC | GO:0044464; cell part | GO:0097443; sorting endosome | 2.483E-03 | 4.660E-01 | PTPN1 |
CC | GO:0044464; cell part | GO:0005641; nuclear envelope lumen | 3.309E-03 | 5.337E-01 | PTGES |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 1.571E-06 | 6.353E-05 | CYP2C9, ALOX12, PTGES |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 2.579E-06 | 6.353E-05 | HSD11B1, CYP2C9, CYP3A4 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 3.665E-06 | 6.353E-05 | HSD11B1, CYP2C9, CYP3A4 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 4.329E-05 | 5.628E-04 | HSD11B1, CYP2C9, ALOX12, CYP3A4, PTGES |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 5.654E-05 | 5.880E-04 | CYP2C9, CYP3A4 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 2.876E-04 | 2.107E-03 | CYP2C9, CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 2.289E-04 | 1.983E-03 | HSD11B1, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 3.241E-04 | 2.107E-03 | CYP2C9, CYP3A4 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 8.513E-04 | 4.919E-03 | CYP2C9, ALOX12 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04010 | MAPK signaling pathway | 4.310E-03 | 2.241E-02 | JUN, MAPT |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
H00-H59: Diseases of the eye and adnexa | Ocular hypertension | H40.0 | HSD11B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Lipid metabolism disorder | E75-E78 | HSD11B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Hypercholesterolemia | E78 | HSD11B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | HSD11B1; |
J00-J99: Diseases of the respiratory system | Influenza virus | J11.1 | HSD11B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Obesity | E66 | HSD11B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Non-insulin dependent diabetes | E11.9 | HSD11B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Metabolic disorders | E70-E89 | HSD11B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Metabolic syndrome x | E88.81 | HSD11B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetes | E23.2, N25.1 | HSD11B1; |
I00-I99: Diseases of the circulatory system | Atherosclerosis | I70 | HSD11B1; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Rheumatoid arthritis | M05-M06 | JUN; |